成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
ChemicalBook
bioleaper 企業(yè)の連絡(luò)先情報(bào)
名前:
bioleaper
電話番號(hào):
-
電子メール:
guojing@bioleaper.com
國(guó)籍:
China
ウェブサイト:
www.bioleaper.com/
商品の合計(jì)數(shù):
5616
45
46
47
48
49
50
51
52
53
54
55
56
57
製品カタログ
Anti-GD3 Reference Antibody (ecromeximab)
Anti-GFRA3 Reference Antibody (nadecnemab)
Anti-GPR64 / ADGRG2 Reference Antibody (Facet patent anti-GPR64)
Anti-GUCY2C Reference Antibody (indusatumab)
Anti-HGFR / c-Met Reference Antibody (onartuzumab)
Anti-Histone H3 Reference Antibody (Immunomedics patent anti-Histone H3)
Anti-IFNAR1 Reference Antibody (Medarex patent anti-IFNAR-1)
Anti-IgE Reference Antibody (ligelizumab)
Anti-IL-12b Reference Antibody (ebdarokimab)
Anti-IL-13 Reference Antibody (dectrekumab)
Anti-GCGR Reference Antibody (volagidemab)
Anti-GPA33 Reference Antibody (KRN330)
Anti-GPR44 / PTGDR2 / CD294 Reference Antibody (KHK patent anti-CRTH2)
Anti-HGF / SF Reference Antibody (ficlatuzumab)
Anti-HGFR / c-Met Reference Antibody (emibetuzumab)
Anti-ICOS / CD278 Reference Antibody (feladilimab)
Anti-IFNa1 Reference Antibody (rontalizumab)
Anti-IGF1R / CD221 Reference Antibody (ganitumab)
Anti-IGF2 Reference Antibody (DX-2647)
Anti-FZD7 Reference Antibody (U.Toronto patent anti-FZD7)
Anti-GM3 Reference Antibody (racotumomab)
Anti-GPC3 / Glypican-3 Reference Antibody (codrituzumab)
Anti-HBEGF Reference Antibody (U3-1565)
Anti-HGF / SF Reference Antibody (TAK-701)
Anti-ICAM1 / CD54 Reference Antibody (bersanlimab)
Anti-IDO2 Reference Antibody (LIMR patent anti-IDO2)
Anti-IGF1R / CD221 Reference Antibody (cixutumumab)
Anti-IGF1R / CD221 Reference Antibody (lonigutamAb)
Anti-IL-13 Reference Antibody (lebrikizumab)
Anti-GDF8 / Myostatin Reference Antibody (apitegromab)
Anti-GFRAL Reference Antibody (NGM120)
Anti-GPR73 / PROKR1 Reference Antibody (Regeneron patent anti-PROKR1)
Anti-H3L Antibody (NAL_A185)
Anti-HGFR / c-Met Reference Antibody (SAIT301)
Anti-Histone H4 Reference Antibody (Immunomedics patent anti-Histone H4)
Anti-IFNg Reference Antibody (AMG 811)
Anti-IgE Reference Antibody (omalizumab)
Anti-IL-13 Reference Antibody (abrezekimab)
Anti-IL-13 Reference Antibody (GSK 679586)
Anti-FZD10 Reference Antibody (tabituximab)
Anti-GD2 Reference Antibody (dinutuximab)
Anti-GPC1 / Glypican-1 Reference Antibody (Minomic patent anti-Glypican 1)
Anti-GPR49 / LGR5 Reference Antibody (BNC101)
Anti-HGF / SF Reference Antibody (rilotumumab)
Anti-HGFR / c-Met Reference Antibody (Korea RIBB patent anti-cMet)
Anti-ICOS / CD278 Reference Antibody (MEDI-570)
Anti-IFNa1 Reference Antibody (sifalimumab)
Anti-IFNg Reference Antibody (fontolizumab)
Anti-IL-10 Reference Antibody (BT-063)
Anti-IL-13 Reference Antibody (cendakimab)
Anti-GDF15 / MIC-1 Reference Antibody (ponsegromab)
Anti-GAD65 Reference Antibody (U.Washington patent anti-GAD65)
Anti-GOLM1 Reference Antibody (Cureab patent anti-GP73)
Anti-GPNMB Reference Antibody (glembatumumab)
Anti-Hepcidin / HAMP Reference Antibody (Ludwig-Maximilians U. anti_Hepsin)
Anti-HGFA Reference Antibody (Genentech patent anti-HGFA )
Anti-ICAM3 / CD50 Reference Antibody (Forerunner patent anti-ICAM-3)
Anti-IFNa1 Reference Antibody (Baylor patent anti-IFN alpha)
Anti-IGF1R / CD221 Reference Antibody (dalotuzumab)
Anti-IGF1R / CD221 Reference Antibody (robatumumab)
Anti-GDF8 / Myostatin Reference Antibody (domagrozumab)
Anti-GIPR Reference Antibody (Amgen patent anti-GIPR)
Anti-GPRC5D Reference Antibody (talquetamab)
Anti-Haptoglobin Reference Antibody (KHK patent anti-Haptoglobin)
Anti-HGFR / c-Met Reference Antibody (telisotuzumab)
Anti-HLA-DR Reference Antibody (IMMU-114)
Anti-IFNg Reference Antibody (emapalumab)
Anti-IgE Reference Antibody (talizumab)
Anti-IL-13 Reference Antibody (anrukinzumab)
Anti-IL-13 Reference Antibody (H2L6)
Anti-GD2 Reference Antibody (EMD 273063)
Anti-GDF8 / Myostatin Reference Antibody (trevogrumab)
Anti-GPR49 / LGR5 Reference Antibody (petosemtamab)
Anti-GREM1 / Gremlin Reference Antibody (UCB patent anti-Gremlin-1)
Anti-HGFR / c-Met Reference Antibody (Metheresis patent anti-Met)
Anti-Histone H2B Reference Antibody (Immunomedics patent anti-Histone H2B)
Anti-IFNAR1 Reference Antibody (anifrolumab)
Anti-IgE (M1 prime) Reference Antibody (quilizumab)
Anti-IL-12 (IL-12a & IL-12b) Reference Antibody (briakinumab)
Anti-IL-13 Reference Antibody (CNTO 607)
Anti-GCGR Reference Antibody (crotedumab)
Anti-GP6 / Glycoprotein-6 Reference Antibody (glenzocimab)
Anti-GPR20 Reference Antibody (DS-6157)
Anti-Hepcidin / HAMP Reference Antibody (LY2787106)
Anti-HGFR / c-Met Reference Antibody (amivantamab)
Anti-ICOS / CD278 Reference Antibody (alomfilimab)
Anti-IFNa1 Reference Antibody (Chinese CDC patent anti-Interferon Alpha)
Anti-IGF1R / CD221 Reference Antibody (figitumumab)
Anti-IGF1R / CD221 Reference Antibody (teprotumumab)
Anti-GD2 Reference Antibody (naxitamab)
Anti-GDF8 / Myostatin Reference Antibody (landogrozumab)
Anti-GLP1R Reference Antibody (Centocor patent anti-GLP-1R)
Anti-GREM1 / Gremlin Reference Antibody (Regeneron patent anti-GREM1)
Anti-HBEGF Reference Antibody (KHK2866)
Anti-Histone H1 Reference Antibody (derlotuximab)
Anti-HTRA1 Reference Antibody (FHTR2163)
Anti-ICOS / CD278 Reference Antibody (vopratelimab)
Anti-IGF1 Reference Antibody (xentuzumab)
Anti-IGF1R / CD221 Reference Antibody (Immunomedics patent anti-IGF-1R)
Anti-IL-13 Reference Antibody (IMA-026)
45
46
47
48
49
50
51
52
53
54
55
56
57
Copyright 2017 ? ChemicalBook. All rights reserved